New registry aims to uncover safety of psychiatric meds in pregnancy

NCT ID NCT01246765

Recruiting now Knowledge-focused Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This registry enrolls 5,000 pregnant women aged 18-45 who take psychiatric medications like antidepressants or ADHD drugs. Researchers track infant health for one year after birth to see if these medications increase the risk of major birth defects. The goal is to provide better safety data for a group where information is currently limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could provide clearer safety information about psychiatric medication use during pregnancy, helping doctors and patients make informed decisions.
What could go wrong: This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may take years and could still leave unanswered questions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANT WOMEN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREGNANT WOMEN PSYCHOTROPIC DRUGS

Contacts and locations

Show contact details

Locations

Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.